WELLS FARGO & COMPANY/MN - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0. A total of 11 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$1,146,000
-28.6%
2,025,0000.0%0.00%
Q2 2022$1,605,000
+20.1%
2,025,0000.0%0.00%
Q1 2022$1,336,000
-11.2%
2,025,0000.0%0.00%
Q4 2021$1,505,000
-10.8%
2,025,0000.0%0.00%
Q3 2021$1,688,000
-14.6%
2,025,0000.0%0.00%
Q2 2021$1,976,000
-12.1%
2,025,0000.0%0.00%
-100.0%
Q1 2021$2,247,000
+28.2%
2,025,0000.0%0.00%
Q4 2020$1,753,000
-11.6%
2,025,0000.0%0.00%
-100.0%
Q3 2020$1,982,0002,025,0000.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 64,842,000$63,520,0003.42%
QVT Financial LP 15,000,000$14,638,0001.79%
ARISTEIA CAPITAL, L.L.C. 22,150,000$21,214,0000.87%
WHITEBOX ADVISORS LLC 9,300,000$8,861,0000.37%
LMR Partners LLP 13,099,000$12,793,0000.26%
CAPSTONE INVESTMENT ADVISORS, LLC 6,100,000$5,842,0000.03%
WOLVERINE ASSET MANAGEMENT LLC 1,500,000$1,442,0000.01%
WELLS FARGO & COMPANY/MN 2,025,000$1,982,0000.00%
DEUTSCHE BANK AG\ 1,968,000$1,875,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CLOVIS ONCOLOGY INC shareholders